SEC Form 4/A · accession 0001209191-15-053880

KYNTRA BIO, INC. · KYNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Officer — Chief Executive Officer · Director · 10% Owner

Period of report

Nov 19, 2014

Accepted (ET)

Jun 16, 2015 · 5:04 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000921299

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	Nov 19, 2014	C	60,946	—	A	60,946	I	See footnote
Common Stock	holding	—	—		—	3,843,162	D
Common Stock	holding	—	—		—	145,070	I	By Family Partnership
Common Stock	holding	—	—		—	20,000	I	By Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock of Fibrogen Europe Oy^F2,F5,F4	—	Nov 19, 2014	C	1,052	D	—	—	Common Stock	770	0	I

F1Each share of the issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into 0.4 of a share of common stock immediately prior to the closing of the issuer's initial public offering, and has no expiration date.
F2Each share of the Fibrogen Europe Oy's Series A Preferred was automatically converted into into 0.732 of a share of common stock immediately prior to the closing of the issuer's initial public offering.
F3The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
F4Not applicable.
F5The shares were held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.

This form 4/A is being filed to add information that was omitted from the original form 4.